Immunogenicity and Safety of Defective Vaccinia Virus Lister: Comparison with Modified Vaccinia Virus Ankara

Potent and safe vaccinia virus vectors inducing cell-mediated immunity are needed for clinical use. Replicating vaccinia viruses generally induce strong cell-mediated immunity; however, they may have severe adverse effects. As a vector for clinical use, we assessed the defective vaccinia virus syste...

ver descrição completa

Detalhes bibliográficos

Publicado no:	J Virol
Principais autores:	Ober, B. T., Brühl, P., Schmidt, M., Wieser, V., Gritschenberger, W., Coulibaly, S., Savidis-Dacho, H., Gerencer, M., Falkner, F. G.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2002
Assuntos:	Gene Therapy
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC136372/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12097585/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.76.15.7713-7723.2002
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!